Medical expulsive therapy
- PMID: 24497685
- PMCID: PMC3897056
- DOI: 10.4103/0970-1591.124209
Medical expulsive therapy
Abstract
The objective of this review article is to present the current literature on medical expulsive therapy (MET) and help guide practitioners in the appropriate use of MET for treatment of stone disease. Kidney stones can be treated with multiple modalities including medical therapy, ureteroscopy, shock wave lithotripsy (SWL), percutaneous nephrostolithotomy, open/laparoscopic stone removal, and/or combinations of these modalities. The choice of intervention depends on patient factors, anatomical considerations, surgeon preference, and stone location and characteristics. MET is an excellent treatment modality in the appropriately selected patient. The AUA/EAU guidelines suggest MET as a reasonable treatment choice in select patients. A review of the data suggests the use of alpha antagonist and calcium channel blockers can improve stone expulsion rates. Most data suggests alpha antagonists as superior to calcium channel blockers. There are numerous available alpha antagonists, all of which have supporting data for their use in MET. Evidence suggests that MET can decrease colic events, narcotic use, and hospital visits. MET may also reduce medical costs and prevent unnecessary surgeries and the associated risks. Further, there is a role for alpha antagonists and calcium channel blockers in improving stone passage and decreasing pain in those subjects treated with other modalities (i.e. SWL and ureteroscopy). Despite this evidence, MET remains underutilized as a treatment modality.
Keywords: Kidney; stones; urolithiasis.
Conflict of interest statement
Similar articles
-
EAU Guidelines on Diagnosis and Conservative Management of Urolithiasis.Eur Urol. 2016 Mar;69(3):468-74. doi: 10.1016/j.eururo.2015.07.040. Epub 2015 Aug 28. Eur Urol. 2016. PMID: 26318710 Review.
-
Ureteral stones: SWL treatment.Arch Ital Urol Androl. 2011 Mar;83(1):10-3. Arch Ital Urol Androl. 2011. PMID: 21585162
-
Medical expulsive therapy versus early endoscopic stone removal for acute renal colic: an instrumental variable analysis.J Urol. 2013 Sep;190(3):882-7. doi: 10.1016/j.juro.2013.03.040. Epub 2013 Mar 19. J Urol. 2013. PMID: 23517746
-
Medical expulsive therapy.Semin Nephrol. 2008 Mar;28(2):192-9. doi: 10.1016/j.semnephrol.2008.01.002. Semin Nephrol. 2008. PMID: 18359400 Review.
-
EAU Guidelines on Interventional Treatment for Urolithiasis.Eur Urol. 2016 Mar;69(3):475-82. doi: 10.1016/j.eururo.2015.07.041. Epub 2015 Sep 4. Eur Urol. 2016. PMID: 26344917 Review.
Cited by
-
To compare the efficacy of tamsulosin and alfuzosin as medical expulsive therapy for ureteric stones.Avicenna J Med. 2017 Jul-Sep;7(3):115-120. doi: 10.4103/ajm.AJM_87_16. Avicenna J Med. 2017. PMID: 28791244 Free PMC article.
-
A comparison of nifedipine and tamsulosin as medical expulsive therapy for the management of lower ureteral stones without ESWL.Sci Rep. 2014 Jun 11;4:5254. doi: 10.1038/srep05254. Sci Rep. 2014. PMID: 24919112 Free PMC article.
-
Role of inflammatory markers and their trends in predicting the outcome of medical expulsive therapy for distal ureteric calculus.Urol Ann. 2022 Jan-Mar;14(1):8-14. doi: 10.4103/ua.ua_139_21. Epub 2021 Dec 28. Urol Ann. 2022. PMID: 35197696 Free PMC article.
References
-
- Tiselius HG. Epidemiology and medical management of stone disease. BJU Int. 2003;91:758–67. - PubMed
-
- Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC. Time trends in reported prevalence of kidney stones in the United States: 1964-1994. Kidney Int. 2003;63:1817–23. - PubMed
-
- Taylor EN, Stampfer MJ, Curhan GC. Diabetes mellitus and the risk of nephrolithiasis. Kidney Int. 2005;68:1230–5. - PubMed
-
- Taylor EN, Stampfer MJ, Curhan GC. Obesity, weight gain, and the risk of kidney stones. JAMA. 2005;293:455–62. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous